- Future Students
- DVM degree program
- Graduate Programs
- Request information
- Contacts, Map, and Directions
- Current Students
- Faculty & Staff
Filters: Keyword is Drug Therapy, Combination [Clear All Filters]
Milovancev M, Schmiedt CW, Bentley E, Schwab M, Dubielzig RR, Gendron-Fitzpatrick AP, McAnulty JF. 2007. Use of capecitabine to prevent acute renal allograft rejection in dog erythrocyte antigen-mismatched mongrel dogs.. Veterinary surgery : VS. 36(1):10-20.
Bermudez LE, Kolonoski P, Seitz LE, Petrofsky M, Reynolds R, Wu M, Young LS. 2004. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.. Antimicrobial agents and chemotherapy. 48(9):3556-8.
Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. 2003. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.. The Journal of infectious diseases. 187(12):1977-80.
Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Aralar P, Wu M, Young LS. 2001. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.. Antimicrobial agents and chemotherapy. 45(1):217-22.
Kemper CA, Bermudez LE, Deresinski SC. 1998. Immunomodulatory treatment of Mycobacterium avium complex bacteremia in patients with AIDS by use of recombinant granulocyte-macrophage colony-stimulating factor.. The Journal of infectious diseases. 177(4):914-20.